Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
73 participants
OBSERVATIONAL
2011-10-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective of our study is to describe the cognitive and communicative development of deaf children implanted from the pre-implant assessment to 18 months post-implantation, by addressing the following aspects:
* The psychomotor and cognitive development assessed using the Brunet-Lézine test;
* The development of preverbal communication, evaluated using the Early Social Communication Scale.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Development of Social Cognition in a Deaf Child With a Cochlear Implant : A Study Using a Standardized Questionnaire
NCT06914531
Neural Prediction to Enhance Language
NCT05962359
Analysis of Language and Auditory Abilities in Cochlear Implanted Children
NCT00947778
Language Development in Cochlear Implant Children
NCT04595552
Analysis of Parental Support in Families Using the LENA After Early Cochlear Implantation
NCT05917496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
12-30 months-old deaf children
Children with deafness of bilateral deep perception had : Evaluation of the detection of non-linguistic sounds, Early Social Communication Scale (ECSP) and psychomotor infancy development scale or Lézine Brunet-Revised scale
Evaluation of the detection of non-linguistic sounds
Evaluation of the detection of non-linguistic sounds (sound room)
Early Social Communication Scale (ECSP)
Early Social Communication Scale (ECSP) evaluation
psychomotor infancy development scale
6-9 years-old deaf children
Free hearing test categorization and NEPSY (two domains: "memory and learning" and "attention and executive functions") in 6-9 years-old deaf child cohort with deafness of bilateral deep perception and carrying a cochlear implant
Free hearing test categorization
Free hearing test categorization evaluation
NEPSY (two domains: "memory and learning" and "attention and executive functions").
NEPSY evaluation
12-30 months-old normal hearing children
Evaluation of the detection of non-linguistic sounds in 12-30 months-old normal hearing child cohort
Evaluation of the detection of non-linguistic sounds
Evaluation of the detection of non-linguistic sounds (sound room)
6-9 years-old normal hearing children
'Free hearing test categorization' in 6-9 years-old normal hearing child cohort
Free hearing test categorization
Free hearing test categorization evaluation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evaluation of the detection of non-linguistic sounds
Evaluation of the detection of non-linguistic sounds (sound room)
Free hearing test categorization
Free hearing test categorization evaluation
Early Social Communication Scale (ECSP)
Early Social Communication Scale (ECSP) evaluation
psychomotor infancy development scale
NEPSY (two domains: "memory and learning" and "attention and executive functions").
NEPSY evaluation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A cohort of deaf children aged 12 to 30 months:
* Be reached a bilateral profound sensorineural hearing loss (greater than 90 dB hearing loss, as classified by the International Bureau for Audiophonology, 1997);
* Raise a cochlear implant;
* Being affiliated to a social security scheme.
* Consent representatives of parental authority (or at least one of the two)
* A cohort of deaf children from 6 to 9 years:
* Be reached a bilateral profound sensorineural hearing loss;
* Be holder of a cochlear implant for at least 3 years;
* Consent representatives of parental authority (or at least one of the two).
* A group of normal hearing typically developing children:
this group will provide benchmarks for perception tests. It consists of two sub-groups:
* Children with normal hearing typically developing 12 to 30 months; children whith a general, linguistic and normal psychomotor evaluated on the basis of prior clinical examination at baseline and on the compilation of their health record. They must not present psychomotor retardation or language.
* Children with normal hearing in typical development 6 to 9 years.
* Be matched in age and sex with deaf children (a pairing with a child on the criteria defined above). In terms of developmental age, we can consider as having comparable in terms of age development of children with:
* +/- 6 months for the population of children 6 to 9 years
* +/- 1 month for the population of children 12 to 30 months.
* Have a typical development, evaluated by a grade level for their age;
* Consent representatives of parental authority (or at least one of the two).
Exclusion Criteria
* Impossible to understand instructions
* Blindness
* Impossible to meet the tests
* Multihandicap
* A legal impossibility. Furthermore, children will be excluded for which there is a refusal on the part of the parents or of the child to participate in the study (for children old enough to express their opinion).
12 Months
9 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier DEGUINE, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Service ORL - Hôpital Purpan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Purpan - Pavillon Dieulafoy - Service ORL (ENT services)
Toulouse, Haute-Garonne, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-A01058-33
Identifier Type: REGISTRY
Identifier Source: secondary_id
11 227 02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.